Capping more than two years of stock-gyrating drama, Pfizer said Monday that it would stop development of danuglipron, its ...

The Office on Smoking and Health at the CDC is no more, putting state quitlines and national data on youth tobacco use at ...

The U.S. capacity to battle hepatitis B and C has been leveled a devastating blow with the recent closure of the CDC’s ...

A program to upgrade technology used by community health centers across the country is in limbo after HHS layoffs.

The recent wave of layoffs and financial troubles at CRISPR-focused startups should not tarnish the promise of CRISPR.

There are many good reasons why the U.S. should pay more for earlier access to new medications than its trading partners.

Verve Therapeutics said Monday that initial data show that its investigational gene-editing therapy lowered cholesterol without inducing serious side effects.

Donald Trump’s doctor says the oldest man to be elected president is “fully fit” to serve as commander in chief as the White ...

In an unusual move, an audit of commercial health plans by Tennessee officials found that Express Scripts, one of the largest ...

The Trump administration’s remaking of HHS — in a matter of weeks — is sparking basic questions about how parts of the agency ...

Health secretary Robert F. Kennedy Jr. has expressed another unorthodox view on vaccines, declaring that single antigen ...

Key NIH advisory councils that approve research grants resumed meeting this week, though the sessions were abbreviated ...